Erlotinib 150mg Tablets IP

Product Description

taking advantage of the abilities and commitment of ourtalented employees, we offer a variety of 150mg Erlotinib Tablets IP.Pancreatic cancer and non-small cell lung cancer are both treated with it. Thedrug is a member of a group of medicines known as epidermal growth factorreceptor inhibitors, which stop the EGFR protein's ability to stimulate thegrowth of cancer cells. Tablets of 150mg Erlotinib IP are retained in theiroriginal packaging and thrown away after the expiration date. It is availablefor a reasonable price. 

Specification